Results

Total Results: 1,806 records

Showing results for "disorder".

81. Depression Screening and Follow-Up for Adolescents and Adults (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/depression/chipra-246-section-2.pdf
    March 01, 2016 - . • Revised the timing for the exclusion for bipolar disorder from “during the Measurement Period or … “Screening for Major Depressive Disorder in Adults: US Preventive Services Task Force Recommendation … Exclusions Exclusions Exclude members with any of the following: • Bipolar disorder during the year … . • Personality disorder. • Psychotic disorder. • Pervasive developmental disorder. • In hospice or using … • Bipolar disorder. • Personality disorder. • Psychotic disorder. • Pervasive developmental disorder

82. AHRQ and National Institute on Drug Abuse Advocate for Research To Advance Equity in Substance Use Disorder Treatment | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/newsletters/e-newsletter/819.html
    June 01, 2022 - AHRQ and National Institute on Drug Abuse Advocate for Research To Advance Equity in Substance Use Disorder … AHRQ and National Institute on Drug Abuse Advocate for Research To Advance Equity in Substance Use Disorder … AHRQ and National Institute on Drug Abuse Advocate for Research To Advance Equity in Substance Use Disorder … Does a rural community-based intervention improve knowledge and attitudes of opioid use disorder and

83. Primary Care Providers in Pennsylvania Use Medication for Successful Treatment of Opioid Use Disorders | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/newsroom/case-studies/202105.html
    November 01, 2021 - LVHN used AHRQ resources to integrate treatment for opioid use disorder into primary care practice. … , a patient can get his diabetes and blood pressure medications, plus his medication for opioid use disorder … universal screening for substance use disorders in outpatient clinics and medications for opioid use disorder

84. Increase in Hospital Inpatient Stays for Opioid Use Disorders and Endocarditis, 2016 | Agency for Healthcare Research and Quality
    www.ahrq.gov/data/infographics/opioid-use-endocarditis.html
    May 01, 2020 - PDF, 1.2 MB) Source: HCUP Statistical Brief #256, Hospital Inpatient Stays Related to Opioid Use Disorder

85. Measure 1, Section 2, Attachment 6 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-2-attachment-6.pdf
    January 17, 2017 - Specification Example DRAFT Measure #1: Accurate Diagnosis of ADHD Attention Deficit Hyperactivity Disorder … Percentage of patients aged 4 through 18 years at initial diagnosis of Attention Deficit Hyperactivity Disorder … be constructed from administrative claims data for this measure Attention Deficit Hyperactivity Disorder

86. Approaches to Address Health Risks for Older Adults
    www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/about/ncepcr-older-adults-presentation.pptx
    January 16, 2025 - healthcare systems to improve opioid medication management and prevent opioid misuse and opioid use disorder … PhD (Ohio State University) Pain, Multimorbidity, Opioid-Drug Interactions and Risk for Opioid Use Disorder … Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose. … Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. … Racial Inequality in Receipt of Medications for Opioid Use Disorder.

87. Final Progress Report: Diagnostic Error in Dystonia (pdf file)
    www.ahrq.gov/sites/default/files/2025-03/tanner-report.pdf
    January 01, 2025 - Primary dystonia, thought to be the third most common movement disorder, is a chronic neurological disease … Initial misdiagnoses as a psychiatric disorder and recommendations for antidepressants or mental health … Scope Primary dystonia, thought to be the third most common movement disorder, is a chronic neurological … (d) How many misdiagnoses as a psychiatric disorder or as a malingerer occurred? … Misdiagnosis as a psychiatric disorder were similar in men and women. Race/ethnicity.

88. Resources for Women’s Health | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/resources/womens-health.html
    July 01, 2018 - Treatment of Depression During Pregnancy and the Postpartum Period Management and Outcomes of Binge-Eating Disorder … the Evidence Nonpharmacological Versus Pharmacological Treatment for Patients With Major Depressive Disorder … Comparing Talk Therapy and Other Depression Treatments With Antidepressant Medicines Managing Insomnia Disorder … Medicines To Treat Alcohol Use Disorder Treating Binge-Eating Disorder Top of Page Muscle, Bone, and

89. New Resource Developed To Help Address Burnout in Primary Care | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/newsletters/e-newsletter/860.html
    April 01, 2023 - Promising Approach Identified for Screening Patients With Alcohol Use Disorder . … Promising Approach Identified for Screening Patients With Alcohol Use Disorder An AHRQ-funded study … interventions in adult patients, but did not result in meaningful changes in treatment for alcohol use disorder … They found the proportion of patients screened for alcohol use disorder and documented in the electronic … Total cost of care associated with opioid use disorder treatment.

90. State Variations in Inpatient Stays for Substance Use Disorders | Agency for Healthcare Research and Quality
    www.ahrq.gov/data/infographics/sud-inpatient-stays.html
    May 01, 2022 - https://hcup-us.ahrq.gov/reports/statbriefs/sb289-Substance-Use-Disorder-Hospitalizations-by-Region-2016

91. The Academy for Integrating Behavioral Health and Primary Care | Agency for Healthcare Research and Quality
    www.ahrq.gov/cpi/about/otherwebsites/integrationacademy.ahrq.gov/index.html
    September 01, 2024 - Medication-Assisted Treatment for Opioid Use Disorder Playbook , a practical guide for implementing medication-assisted … treatment for opioid use disorder in primary care.

92. Tool 11: Community Resource Guide (doc file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/medicaidreadmitguide/mcaidread_tool11_comm_resource.docx
    September 12, 2016 - navigators and peer advocacy specialists available for patients with xxx needs] Substance Use Disorder … [Regional Community Behavioral Health Service Provider] [Point person] [XXX] [Substance Use Disorder … Substance Use Disorder Treatment Courage Recovery Center Contact: Bob, Director (555) 555-4321 Services … Substance Use Disorder Treatment Readmissions County Cares Contact: Chelsea, Director (555) 555-6666 … Substance Use Disorder Treatment MedReadmissions Treatment Centers Contact: Terry, Program Director

93. Search Evidence-Based Reports | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
    January 01, 2021 - Report Status: Final Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder … Final Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder … Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder

94. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=393
    January 01, 2024 - Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the … The researchers sought to determine if eczema is associated with an increased risk of a speech disorder … They found that pooled prevalence of speech disorder in children with eczema was 4.7 percent compared … They concluded that pediatric eczema may be associated with increased risk of speech disorder. … Eczema is associated with childhood speech disorder: a retrospective analysis from the National Survey

95. Hospital Readmissions for Psychiatric Conditions (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/data/infographics/psychiatric-hospital-readmissions.pdf
    May 28, 2015 - infographic shows that patients with schizophrenia or mood disorders, such as depression or bipolar disorder

96. Behavior Therapy as First-Line Treatment for Preschool-Aged Children with ADHD | Agency for Healthcare Research and Quality
    www.ahrq.gov/pqmp/measures/behavior-therapy.html
    August 01, 2021 - Measure Domain:  Management of Chronic Conditions Measure Sub-Domain:  Attention Deficit/Hyperactivity Disorder

97. Opioids and Substance Use Disorders | Agency for Healthcare Research and Quality
    www.ahrq.gov/opioids/index.html
    Data and Analytics Quantifying and providing insight into the substance use disorder

98. Opioids AHRQ Works: Building Bridges Between Research and Practice (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/topics/impact-opioid-final.pdf
    November 01, 2018 - FDA-approved medications combined with psychosocial treatments, is an effective way to treat opioid use disorder … categorized by topic and address the full spectrum of needs for patients with or at risk for opioid use disorder …  Medication-Assisted Treatment Models of Care for Opioid Use Disorder in Primary Care Settings. … /products/opioid-substance-use-resources https://www.effectivehealthcare.ahrq.gov/topics/opioid-use-disorder … /technical-brief https://www.effectivehealthcare.ahrq.gov/topics/opioid-use-disorder/technical-brief

99. Table 28. Logistic regression of characteristics associated with utilization of education and case management visits by adults with diabetes or cardiovascular disease. | Agency for Healthcare Research and Quality
    www.ahrq.gov/practiceimprovement/delivery-initiative/ihs/chap6tab28.html
    December 01, 2017 - 0.002 Hypertension 0.87 0.164 Renal disease/failure 1.20 0.001 Mental health disorder … 1.00 0.973 Liver disease 0.74 0.084 Substance use disorder        

100. Table 27. Utilization of education and case management (ECM) visits among adults with diabetes or cardiovascular disease by patient characteristics. All project sites. Fisca | Agency for Healthcare Research and Quality
     www.ahrq.gov/practiceimprovement/delivery-initiative/ihs/chap6tab27.html
     December 01, 2017 - Hypertension 1.1 36.9% 3.0 Renal disease/failure 1.1 34.7% 3.2 Mental health disorder … 1.1 36.4% 3.1 Liver disease 1.0 32.6% 3.1 Substance use disorder 0.7 25.6%